These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 29071508)

  • 1. Pharmacological Chaperones: Beyond Conformational Disorders.
    Leidenheimer NJ
    Handb Exp Pharmacol; 2018; 245():135-153. PubMed ID: 29071508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological chaperoning: a primer on mechanism and pharmacology.
    Leidenheimer NJ; Ryder KG
    Pharmacol Res; 2014 May; 83():10-9. PubMed ID: 24530489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein Misfolding Diseases and Therapeutic Approaches.
    Yadav K; Yadav A; Vashistha P; Pandey VP; Dwivedi UN
    Curr Protein Pept Sci; 2019; 20(12):1226-1245. PubMed ID: 31187709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacoperone drugs: targeting misfolded proteins causing lysosomal storage-, ion channels-, and G protein-coupled receptors-associated conformational disorders.
    Hou ZS; Ulloa-Aguirre A; Tao YX
    Expert Rev Clin Pharmacol; 2018 Jun; 11(6):611-624. PubMed ID: 29851355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological Chaperones as Potential Therapeutic Strategies for Misfolded Mutant Vasopressin Receptors.
    Mouillac B; Mendre C
    Handb Exp Pharmacol; 2018; 245():63-83. PubMed ID: 28939971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting opioid receptors with pharmacological chaperones.
    Petäjä-Repo UE; Lackman JJ
    Pharmacol Res; 2014 May; 83():52-62. PubMed ID: 24355364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteostasis: bad news and good news from the endoplasmic reticulum.
    Noack J; Brambilla Pisoni G; Molinari M
    Swiss Med Wkly; 2014; 144():w14001. PubMed ID: 25144910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using pharmacological chaperones to restore proteostasis.
    Wang YJ; Di XJ; Mu TW
    Pharmacol Res; 2014 May; 83():3-9. PubMed ID: 24747662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early Stage Discovery and Validation of Pharmacological Chaperones for the Correction of Protein Misfolding Diseases.
    Aubi O; Knappskog PM; Martinez A
    Methods Mol Biol; 2019; 1873():279-292. PubMed ID: 30341617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Underlying mechanisms and chemical/biochemical therapeutic approaches to ameliorate protein misfolding neurodegenerative diseases.
    Hekmatimoghaddam S; Zare-Khormizi MR; Pourrajab F
    Biofactors; 2017 Nov; 43(6):737-759. PubMed ID: 26899445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacoperones as Novel Therapeutics for Diverse Protein Conformational Diseases.
    Tao YX; Conn PM
    Physiol Rev; 2018 Apr; 98(2):697-725. PubMed ID: 29442594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacoperones for Misfolded Gonadotropin Receptors.
    Newton CL; Anderson RC
    Handb Exp Pharmacol; 2018; 245():111-134. PubMed ID: 29043503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of misfolding in rare enzymatic deficits and use of pharmacological chaperones as therapeutic approach.
    Pampalone G; Grottelli S; Gatticchi L; Lombardi EM; Bellezza I; Cellini B
    Front Biosci (Landmark Ed); 2021 Dec; 26(12):1627-1642. PubMed ID: 34994177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening methods for identifying pharmacological chaperones.
    Shin MH; Lim HS
    Mol Biosyst; 2017 Mar; 13(4):638-647. PubMed ID: 28265599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological chaperones for the misfolded melanocortin-4 receptor associated with human obesity.
    Huang H; Wang W; Tao YX
    Biochim Biophys Acta Mol Basis Dis; 2017 Oct; 1863(10 Pt A):2496-2507. PubMed ID: 28284973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological chaperones: a new twist on receptor folding.
    Morello JP; Petäjä-Repo UE; Bichet DG; Bouvier M
    Trends Pharmacol Sci; 2000 Dec; 21(12):466-9. PubMed ID: 11121835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein misfolding in disease and small molecule therapies.
    Gomes CM
    Curr Top Med Chem; 2012; 12(22):2460-9. PubMed ID: 23339300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacoperones as a New Therapeutic Approach: In Vitro Identification and In vivo Validation of Bioactive Molecules.
    Ulloa-Aguirre A; Conn PM
    Curr Drug Targets; 2016; 17(13):1471-81. PubMed ID: 26953247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological correction of misfolding of ABC proteins.
    Rudashevskaya EL; Stockner T; Trauner M; Freissmuth M; Chiba P
    Drug Discov Today Technol; 2014 Jun; 12(100):e87-94. PubMed ID: 25027379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Innovative strategies to treat protein misfolding in inborn errors of metabolism: pharmacological chaperones and proteostasis regulators.
    Muntau AC; Leandro J; Staudigl M; Mayer F; Gersting SW
    J Inherit Metab Dis; 2014 Jul; 37(4):505-23. PubMed ID: 24687294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.